Is 18F-fluorodeoxyglucose positron emission tomography/computed tomography helpful in the decision-making process for neck dissection in patients with T1-T2 lingual cancer?

References

• Kowalski LP. Results of salvage treatment of the neck in patients with oral cancer. Arch Otolaryngol Head Neck Surg 2002;128:58–62.
   PubMedGoogle Scholar
• Lydiatt DD, Robbins KT, Byers RM, Wolf PF. Treatment of stage I and II oral tongue cancer. Head Neck 1993;15:308–12.
   PubMedGoogle Scholar
• Haddadin KJ, Soutar DS, Oliver RJ, Webster MH, Robertson AG, MacDonald DG. Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection. Head Neck 1999;21:517–25.
   PubMed Web of Science ®Google Scholar
• Spiro RH, Huvos AG, Wong GY, Spiro JD, Gnecco CA, Strong EW. Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of the mouth. Am J Surg 1986;152:345–50.
   PubMed Web of Science ®Google Scholar
• Asakage T, Yokose T, Mukai K, Tsugane S, Tsubono Y, Asai M, et al. Tumor thickness predicts cervical metastasis in patients with stage I/II carcinoma of the tongue. Cancer 1998;82:1443–8.
   PubMed Web of Science ®Google Scholar
• Sparano A, Weinstein G, Chalian A, Yodul M, Weber R. Multivariate predictors of occult neck metastasis in early oral tongue cancer. Otolaryngol Head Neck Surg 2004;131:472–6.
   PubMed Web of Science ®Google Scholar
• Beenken SW, Krontiras H, Maddox WA, Peters GE, Soong S, Urist MM. T1 and T2 squamous cell carcinoma of the oral tongue: prognostic factors and the role of elective lymph node dissection. Head Neck 1999;21:124–30.
   PubMedGoogle Scholar
• Pentenero M, Cistaro A, Brusa M, Ferraris MM, Pezzuto C, Carnino R, et al. Accuracy of 18F-FDG-PET/CT for staging of oral squamous cell carcinoma. Head Neck 2008;30:1488–96.
   PubMedGoogle Scholar
• Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, et al. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med 2005;46:1136–43.
   PubMed Web of Science ®Google Scholar
• Bennet JA, Deol P, Abrahams JJ. 2007. Imaging of patients with oral cancer. In Werning JW, editor. Oral cancer diagnosis, management and rehabilitation. New York: Thieme. p 54–65.
   Google Scholar
• Asakage T, Kishimoto S, Saikawa M, Hayashi R, Kawabata K, Sugasawa M, et al. The standardization of neck dissection for tongue carcinoma. Jpn J Head Neck Cancer 2005;31:536–40.
   Google Scholar
• Nieuwenhuis EJ, Castelijns JA, Pijpers R, van den Brekel MW, Brakenhoff RH, van der Waal I, et al. Wait-and-see policy for the N0 neck in early-stage oral and oropharyngeal squamous cell carcinoma using ultrasonography-guided cytology: is there a role for identification of the sentinel node? Head Neck 2002;24:282–9.
   PubMedGoogle Scholar
• van den Brekel MW, Castelijns JA, Reitsma LC, Leemans CR, van der Waal I, Snow GB. Outcome of observing the N0 neck using ultrasonographic-guided cytology for follow-up. Arch Otolaryngol Head Neck Surg 1999;125:153–6.
   PubMedGoogle Scholar
• van den Brekel MW. US-guided fine-needle aspiration cytology of neck nodes in patients with N0 disease. Radiology 1996;201:580–1.
   PubMedGoogle Scholar
• Takes RP, Knegt P, Manni JJ, Meeuwis CA, Marres HA, Spoelstra HA, et al. Regional metastasis in head and neck squamous cell carcinoma: revised value of US with US-guided FNAB. Radiology 1996;198:819–23.
   PubMedGoogle Scholar
• Righi PD, Kopecky KK, Caldemeyer KS, Ball VA, Weisberger EC, Radpour S. Comparison of ultrasound-fine needle aspiration and computed tomography in patients undergoing elective neck dissection. Head Neck 1997;19:604–10.
   PubMed Web of Science ®Google Scholar
• Schoder H, Carlson DL, Kraus DH, Stambuk HE, Gonen M, Erdi YE, et al. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med 2006;47:755–62.
   PubMed Web of Science ®Google Scholar
• Yamazaki Y, Saitoh M, Notani K, Tei K, Totsuka Y, Takinami S, et al. Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer. Ann Nucl Med 2008;22:177–84.
   PubMed Web of Science ®Google Scholar
• Hain SF, Curran KM, Beggs AD, Fogelman I, O’Doherty MJ, Maisey MN. FDG-PET as a "metabolic biopsy" tool in thoracic lesions with indeterminate biopsy. Eur J Nucl Med 2001;28:1336–40.
   PubMedGoogle Scholar
• Beggs AD, Hain SF, Curran KM, O’Doherty MJ. FDG-PET as a "metabolic biopsy" tool in non-lung lesions with indeterminate biopsy. Eur J Nucl Med Mol Imaging 2002;29:542–6.
   PubMedGoogle Scholar
• Murakami R, Uozumi H, Hirai T, Nishimura R, Shiraishi S, Ota K, et al. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2007;68:377–82.
   PubMedGoogle Scholar